Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLANZAPINE vs OLAPARIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLANZAPINE vs OLAPARIB: Safety Overview

Metric OLANZAPINE OLAPARIB
Total FAERS Reports 51,444 18,274
Deaths Reported 5,535 5,496
Death Rate 10.8% 30.1%
Hospitalizations 21,934 3,471
Average Patient Age 44.3 yrs 62.3 yrs
% Female Patients 46.1% 79.9%
FDA Approval Date Apr 23, 2012 Aug 17, 2017
Manufacturer REMEDYREPACK INC. AstraZeneca Pharmaceuticals LP
Route ORAL ORAL
Marketing Status Prescription Discontinued